Horizon Pharma to Present at the 11th Annual JMP Securities Research Conference
* Reuters is not responsible for the content in this press release.
DEERFIELD, IL, May 02 (Marketwire) -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Timothy P. Walbert, chairman, president and chief executive officer, will present at the JMP Securities Research Conference on Monday, May 14, 2012 at 10:00 a.m. Pacific Time (1:00 p.m. Eastern time) in San Francisco, CA. Mr. Walbert will provide an overview of the Company and its corporate activities. The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for 10 business days. About Horizon Pharma Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. For more information, please visit www.horizonpharma.com. Contacts Robert J. De Vaere Executive Vice President and Chief Financial Officer email@example.com Investors Kathy Galante Burns McClellan, Inc. 212-213-0006 firstname.lastname@example.org Copyright 2012, Marketwire, All rights reserved. -0-
- Special Report: Thailand secretly supplies Myanmar refugees to trafficking rings |
- The 10 Most Corrupt and Least Corrupt Countries in the World
- NSA gathers data on cellphone locations globally: report
- China's airspace zone has caused apprehension: Biden |
- China central bank warns banks against use of bitcoin